Search

everythinglearnresearchcommunity

for

Search:↓

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Alstonia boonei phytochemicals show promise as alternative treatments for BPH with fewer side effects than current drugs.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

New compounds were made that are promising for prostate cancer therapy.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Parthenolide promotes hair growth in mice and may influence pathways related to male pattern baldness.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

New steroid derivatives show promise as anticancer agents, even against resistant cells.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

New sulfur-containing steroid analogs show promise for more targeted medical treatments.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

Polydopamine is promising for personalized medicine and biomedical technology due to its strong adhesion and biocompatibility.

Injecting patients' own PRP into their thyroid improved thyroid function and symptoms in most hypothyroidism cases.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Vitamin D analogues can significantly help hair regrowth in Alopecia Areata patients.

Metyrapone effectively stabilizes severe Cushing's disease symptoms before surgery.